Verified· 2 sources

ODI Pharma Schweiz AG

Summary

About the company

The core activity of ODI Pharma is the development, production and distribution of medical cannabis in Europe. The company focuses on the manufacture of pharmaceutical cannabis products in strict compliance with EU GMP and GDP standards and supplies them to pharmacies, clinics and hospitals in 23 European countries. In addition, ODI Pharma also offers white-label services, where the company manufactures and delivers high-quality products for other brands.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

✓ Offered4

Medical Cannabis

Medical cannabis in the form of dried flowers, oils, capsules, tablets and oromucosal spray; produced under strict medical controls and available only on prescription.

Distribution of Medical Cannabis Products

Distribution of pharmaceutical cannabis finished medicines via a European network with supply contracts to pharmacies, specialty clinics and hospitals, initially with a focus on Eastern European markets.

Manufacturing of Pharmaceutical Cannabis Finished Medicines

Production of pharmaceutical cannabis finished medicines under government oversight and regulation for the medical market.

Support for the Medical Cannabis Market

Supporting market players, patients and medical professionals, and accompanying the implementation of a regulated medical cannabis market in Europe.

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

ODI Pharma Schweiz AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

ODI Pharma Schweiz AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

ODI Pharma Schweiz AG in comparison

Industry comparisons are coming soon

Similar companies